187 related articles for article (PubMed ID: 28163820)
1. Apolipoprotein CIII Overexpression-Induced Hypertriglyceridemia Increases Nonalcoholic Fatty Liver Disease in Association with Inflammation and Cell Death.
Paiva AA; Raposo HF; Wanschel AC; Nardelli TR; Oliveira HC
Oxid Med Cell Longev; 2017; 2017():1838679. PubMed ID: 28163820
[TBL] [Abstract][Full Text] [Related]
2. APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.
Cheng X; Yamauchi J; Lee S; Zhang T; Gong Z; Muzumdar R; Qu S; Dong HH
J Biol Chem; 2017 Mar; 292(9):3692-3705. PubMed ID: 28115523
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of apolipoprotein CIII increases and CETP reverses diet-induced obesity in transgenic mice.
Salerno AG; Silva TR; Amaral ME; Alberici LC; Bonfleur ML; Patrício PR; Francesconi EP; Grassi-Kassisse DM; Vercesi AE; Boschero AC; Oliveira HC
Int J Obes (Lond); 2007 Oct; 31(10):1586-95. PubMed ID: 17471296
[TBL] [Abstract][Full Text] [Related]
4. ABCA1 promotes the de novo biogenesis of apolipoprotein CIII-containing HDL particles in vivo and modulates the severity of apolipoprotein CIII-induced hypertriglyceridemia.
Kypreos KE
Biochemistry; 2008 Sep; 47(39):10491-502. PubMed ID: 18767813
[TBL] [Abstract][Full Text] [Related]
5. Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E.
Ebara T; Ramakrishnan R; Steiner G; Shachter NS
J Clin Invest; 1997 Jun; 99(11):2672-81. PubMed ID: 9169497
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a hypertriglyceridemic transgenic miniature pig model expressing human apolipoprotein CIII.
Wei J; Ouyang H; Wang Y; Pang D; Cong NX; Wang T; Leng B; Li D; Li X; Wu R; Ding Y; Gao F; Deng Y; Liu B; Li Z; Lai L; Feng H; Liu G; Deng X
FEBS J; 2012 Jan; 279(1):91-9. PubMed ID: 22023023
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein CIII Reduction Protects White Adipose Tissues against Obesity-Induced Inflammation and Insulin Resistance in Mice.
Recio-López P; Valladolid-Acebes I; Berggren PO; Juntti-Berggren L
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008488
[TBL] [Abstract][Full Text] [Related]
8. Reduced high density lipoprotein cholesterol in severe hypertriglyceridemic ApoCIII transgenic mice via lowered hepatic ApoAI synthesis.
Han Y; Qi R; Liu G
Biochem Biophys Res Commun; 2015 Jul; 462(4):420-5. PubMed ID: 25969427
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.
Andrade JM; Paraíso AF; de Oliveira MV; Martins AM; Neto JF; Guimarães AL; de Paula AM; Qureshi M; Santos SH
Nutrition; 2014; 30(7-8):915-9. PubMed ID: 24985011
[TBL] [Abstract][Full Text] [Related]
10. Hypertriglyceridemia and delayed clearance of fat load in transgenic rabbits expressing human apolipoprotein CIII.
Ding Y; Wang Y; Zhu H; Fan J; Yu L; Liu G; Liu E
Transgenic Res; 2011 Aug; 20(4):867-75. PubMed ID: 21120692
[TBL] [Abstract][Full Text] [Related]
11. Targeting arginase-II protects mice from high-fat-diet-induced hepatic steatosis through suppression of macrophage inflammation.
Liu C; Rajapakse AG; Riedo E; Fellay B; Bernhard MC; Montani JP; Yang Z; Ming XF
Sci Rep; 2016 Feb; 6():20405. PubMed ID: 26846206
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease.
Lee HJ; Yeon JE; Ko EJ; Yoon EL; Suh SJ; Kang K; Kim HR; Kang SH; Yoo YJ; Je J; Lee BJ; Kim JH; Seo YS; Yim HJ; Byun KS
World J Gastroenterol; 2015 Dec; 21(45):12787-99. PubMed ID: 26668503
[TBL] [Abstract][Full Text] [Related]
13. Decoding cell death signals in liver inflammation.
Brenner C; Galluzzi L; Kepp O; Kroemer G
J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
[TBL] [Abstract][Full Text] [Related]
14. Effects of Callistephus chinensis flower polyphones on improving metabolic disorders in high-fat diet-induced mice.
Bi X; Liu W; Xia X; Chen L; Mu T; Liu J; Hou Y; Zhao Y
Food Funct; 2014 Dec; 5(12):3304-10. PubMed ID: 25367327
[TBL] [Abstract][Full Text] [Related]
15. Receptor interacting protein 3 protects mice from high-fat diet-induced liver injury.
Roychowdhury S; McCullough RL; Sanz-Garcia C; Saikia P; Alkhouri N; Matloob A; Pollard KA; McMullen MR; Croniger CM; Nagy LE
Hepatology; 2016 Nov; 64(5):1518-1533. PubMed ID: 27301788
[TBL] [Abstract][Full Text] [Related]
16. Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD.
Luo Y; Burrington CM; Graff EC; Zhang J; Judd RL; Suksaranjit P; Kaewpoowat Q; Davenport SK; O'Neill AM; Greene MW
Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E418-39. PubMed ID: 26670487
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein CIII overexpression exacerbates diet-induced obesity due to adipose tissue higher exogenous lipid uptake and retention and lower lipolysis rates.
Raposo HF; Paiva AA; Kato LS; de Oliveira HC
Nutr Metab (Lond); 2015; 12():61. PubMed ID: 26705406
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein CI causes hypertriglyceridemia independent of the very-low-density lipoprotein receptor and apolipoprotein CIII in mice.
van der Hoogt CC; Berbée JF; Espirito Santo SM; Gerritsen G; Krom YD; van der Zee A; Havekes LM; van Dijk KW; Rensen PC
Biochim Biophys Acta; 2006 Feb; 1761(2):213-20. PubMed ID: 16478678
[TBL] [Abstract][Full Text] [Related]
19. Lowering apolipoprotein CIII protects against high-fat diet-induced metabolic derangements.
Valladolid-Acebes I; Åvall K; Recio-López P; Moruzzi N; Bryzgalova G; Björnholm M; Krook A; Alonso EF; Ericsson M; Landfors F; Nilsson SK; Berggren PO; Juntti-Berggren L
Sci Adv; 2021 Mar; 7(11):. PubMed ID: 33712458
[TBL] [Abstract][Full Text] [Related]
20. Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease.
Kim S; Hong J; Jeon R; Kim HS
Nutr Res; 2016 Jan; 36(1):90-100. PubMed ID: 26773785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
